{"organizations": [], "uuid": "8713c6fc657b97ebf8af0a0fef654b021c292f72", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-savara-announces-ind-approval-for/brief-savara-announces-ind-approval-for-expansion-of-molgradex-phase-3-study-into-u-s-idUSFWN1Q20U2", "country": "US", "domain_rank": 408, "title": "BRIEF-Savara Announces IND Approval For Expansion Of Molgradex Phase 3 Study Into U.S.", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-12T15:08:00.000+02:00", "replies_count": 0, "uuid": "8713c6fc657b97ebf8af0a0fef654b021c292f72"}, "author": "", "url": "https://www.reuters.com/article/brief-savara-announces-ind-approval-for/brief-savara-announces-ind-approval-for-expansion-of-molgradex-phase-3-study-into-u-s-idUSFWN1Q20U2", "ord_in_thread": 0, "title": "BRIEF-Savara Announces IND Approval For Expansion Of Molgradex Phase 3 Study Into U.S.", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "ind approval for expansion of molgradex phase", "sentiment": "negative"}, {"name": "savara inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 11 PM / in 7 minutes BRIEF-Savara Announces IND Approval For Expansion Of Molgradex Phase 3 Study Into U.S. Reuters Staff \nFeb 12 (Reuters) - Savara Inc: \n* SAVARA ANNOUNCES IND APPROVAL FOR EXPANSION OF MOLGRADEX PHASE 3 STUDY INTO U.S. \n* SAVARA - ANTICIPATE THAT TOP LINE RESULTS FOR MOLGRADEX PHASE 3 STUDY WILL BE AVAILABLE IN Q2 OF 2019 Source text for Eikon:  ", "external_links": [], "published": "2018-02-12T15:08:00.000+02:00", "crawled": "2018-02-12T15:26:38.002+02:00", "highlightTitle": ""}